REZDIFFRA
NDC 82576-080, resmetirom, tablet, coated, from Madrigal Pharmaceuticals, Inc..
- Product NDC
- 82576-080
- Status
- Listed
- Labeler
- Madrigal Pharmaceuticals, Inc.
- Dosage form
- TABLET, COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA217785
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/82576-080 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- RESMETIROM80 mg/1
Pharmacologic classes
Breast Cancer Resistance Protein Inhibitors [MoA]; Cytochrome P450 2C8 Inhibitors [MoA]; Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]; Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]; Thyroid Hormone Receptor beta Agonist [EPC]; Thyroid Hormone Receptor beta Agonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 82576-080-30 | 82576008030 | 30 TABLET, COATED in 1 BOTTLE (82576-080-30) |
| 82576-080-90 | 82576008090 | 90 TABLET, COATED in 1 BOTTLE (82576-080-90) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/e67ea09f-a840-439c-86c8-f98585f978b2
Use it
Look up 82576-080 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/82576-080 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 82576-080. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.